News and Trends 12 Jan 2023
Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer
Ajinomoto Co., Inc. has signed a license agreement with Exelixis, Inc. to incorporate AJICAP, Ajinomoto Co.'s proprietary site-specific bioconjugation and…